MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2402416.pdf
Reference134 articles.
1. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW . MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2 Proc Natl Acad Sci USA 1993 90: 3516–3520
2. Kozopas KM, Buchan HL, Craig RW . Improved coupling between proliferation-arrest and differentiation-induction in ML-1 human myeloblastic leukemia cells J Cell Physiol 1990 145: 575–586
3. Yang T, Kozopas KM, Craig RW . The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2 J Cell Biol 1995 128: 1173–1184
4. Yang T, Buchan HL, Townsend KJ, Craig RW . MCL-1, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation J Cell Physiol 1996 166: 523–536
5. Klampfer L, Zhang J, Nimer SD . GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of Bcl-2 and Mcl-1 Cytokine 1999 11: 849–855
Cited by 252 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Protective Effects of Mcl-1 on Mitochondrial Damage and Oxidative Stress in Imiquimod-Induced Cancer Cell Death;Cancers;2024-09-02
2. Alternative Splicing of Pre-mRNA Matters in Oral Diseases;Current Gene Therapy;2024-07-23
3. Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis;Cellular Oncology;2024-06-18
4. Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis;2024-01-19
5. Alternative Splicing Landscape of Head and Neck Squamous Cell Carcinoma;Technology in Cancer Research & Treatment;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3